Prostate cancer patients with detectable post-operative PSA should receive...
Prostate cancer patients with detectable prostate specific antigen (PSA) following radical prostatectomy should receive earlier, more aggressive radiation therapy treatment, according to a study...
View ArticleGenomeDx announces publication of positive validation study for Decipher...
GenomeDx Biosciences today announced the publication of a positive validation study for the Decipher® Prostate Cancer Classifier, a genomic test for prostate cancer. The study, published in the Journal...
View ArticleCabazitaxel therapy may be more effective in treating prostate cancer
Prostate cancer is the second leading cause of cancer for men in the United States. Only one class of chemotherapy called taxanes is effective against the disease.
View ArticleResearch findings lay groundwork for improving treatment assessment for men...
UCLA researchers have found that radiation therapy is the most common treatment for men with prostate cancer regardless of the aggressiveness of the tumor, risk to the patient and overall patient...
View ArticleResearchers evaluate decision aids for patient's choice of localised prostate...
Doctors strive to make treatment decisions together with their patients - but is the decision really shared? According to adjunct professor Kari Tikkinen, shared decision-making isn't easy, and...
View ArticleNovel Ga-68-PSMA-ligand PET/CT effective for early detection of prostate...
A recent study reported in The Journal of Nuclear Medicine compared use of the novel Ga-68-PSMA-ligand PET/CT with other imaging methods and found that it had substantially higher detection rates of...
View ArticleQuitting smoking can help improve outcomes after major urologic surgery
Quitting smoking can lead to a significant improvement in outcomes after major urologic surgery. These new data and their impact on urologic surgery will be highlighted by study authors during a...
View ArticleCurrent fee-for-service models in U.S. healthcare may jeopardize prostate...
A "perverse disincentive" for hospitals that have invested in expensive technology for robotic surgery may be jeopardizing prostate cancer patients who seek out the procedure, concluded a new study led...
View ArticleDecipher Prostate Cancer Classifier predicts metastasis in patients treated...
GenomeDx Biosciences today announced that data presented at the 2015 American Society of Clinical Oncology Annual Meeting demonstrate that the Decipher® Prostate Cancer Classifier is a significant...
View ArticleInternational study provides evidence of clear link between smoking and risk...
Smoking is a known risk factor for the development of various forms of cancer. However, when it comes to the link between smoking and prostate cancer, the findings of previous studies have been...
View ArticleMyriad Genetics and Tufts Health Plan sign agreement to cover Prolaris® for...
Myriad Genetics, Inc. (NASDAQ: MYGN) has announced that it has signed a three-year contract with Tufts Health Plan through which the plan will provide coverage of Prolaris® for members diagnosed with...
View ArticleTransition Therapeutics Ireland signs agreement for investigator-led TT701...
Transition Therapeutics Inc. announced today that Transition Therapeutics Ireland Limited has entered into an agreement for an investigator-led clinical study of drug candidate, TT701, with Brigham and...
View ArticleStudy: Prostate surgery patients have unrealistic expectations regarding...
Patients who have undergone radical prostatectomy often have largely unrealistic expectations with regard to their postoperative sexual function, new research shows.
View ArticleAfrican American men with prostate cancer have significantly lower PSA...
A new study published in The Journal of Urology revealed that African American men with Gleason score 3+3=6 prostate cancer (PCa) produce less prostate specific antigen (PSA) and have significantly...
View ArticleNew imaging test detects prostate cancer much better than any other tests in...
Researchers at Thomas Jefferson University have found the method they developed to image the prostate appears to be much better at detecting prostate cancer than any other test — radiographical, biopsy...
View ArticleNew prognostic biomarker may help determine risk of prostate cancer-related...
Researchers at the University of Copenhagen have identified a new prognostic biomarker: the neuropeptide pro-NPY, which may help determine the risk of dying from prostate cancer. This particular type...
View ArticleStudy looks at post-treatment resources for prostate cancer patients...
The System Partner of Rutgers Cancer Institute of New Jersey, Meridian Health is joining forces with Rutgers Cancer Institute in offering access to a research study aimed at prostate cancer patients...
View ArticleASTRO's new research journal 'Advances in Radiation Oncology' closes first issue
Advances in Radiation Oncology, ASTRO's new original research journal, has closed its first issue with research including a phase II clinical trial in prostate cancer, a prospective trial in quality of...
View ArticleActive surveillance recommended for low-risk prostate cancer
For most men with low-risk prostate cancer, the recommended strategy is active surveillance with regular testing to check for cancer growth rather than immediate treatment, according to guidelines from...
View ArticleLight reflectance spectroscopy may lead to real-time tissue analysis during...
Researchers at UT Southwestern Medical Center have determined that light reflectance spectroscopy can differentiate between malignant and benign prostate tissue with 85 percent accuracy, a finding that...
View Article
